Synchrony Medical Consultancy Limited - Accounts to registrar (filleted) - small 23.1.2

REGISTERED NUMBER: 12623269 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2022

FOR

SYNCHRONY MEDICAL CONSULTANCY LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

Dr J A M McEwan

REGISTERED OFFICE:

3 Woodrough Copse

Bramley

Guildford

Surrey

GU5 0HH

REGISTERED NUMBER:

12623269 (England and Wales)

ACCOUNTANTS:

Romsey Accountants GDT Limited

Unit 3, Shelley Farm

Shelley Lane

Ower

Romsey

Hampshire

SO51 6AS

FIXED ASSETS

Tangible assets

4

584

399

CURRENT ASSETS

Debtors

5

10,038

19,436

Cash at bank

1,064

320

11,102

19,756

CREDITORS

Amounts falling due within one year

6

5,762

6,237

NET CURRENT ASSETS

5,340

13,519

TOTAL ASSETS LESS CURRENT LIABILITIES

5,924

13,918

CAPITAL AND RESERVES

Called up share capital

1,000

1,000

Retained earnings

4,924

12,918

5,924

13,918

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 23 May 2023 and were signed by:

Dr J A M McEwan - Director

1.	STATUTORY INFORMATION

Synchrony Medical Consultancy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

33% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern

The Director has considered the possible effects on the company of the impacts of the worldwide pandemic caused by the coronavirus (Covid-19). Taking into account a period exceeding 12 months from the date of approval of these financial statements, the Director has a reasonable expectation that it has adequate resources to continue in operational existence for the foreseeable future, and for this reason will continue to adopt the going concern basis in the preparation of its financial statements.

Financial instruments

The company enters into basis financial instruments, which result in the recognition of financial assets and liabilities. Financial instruments are recognised at amortised cost. At the end of each reporting period, financial instruments are assessed for evidence of impairment and changes are recognised in the statement of income and retained earnings.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2021 - NIL ) .

4.	TANGIBLE FIXED ASSETS

Computer

equipmen

£

COST

At 1 June 2021

599

Additions

576

At 31 May 2022

1,175

DEPRECIATION

At 1 June 2021

200

Charge for year

391

At 31 May 2022

591

NET BOOK VALUE

At 31 May 2022

584

At 31 May 2021

399

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.5.22

31.5.21

£

£

Other debtors

10,038

19,436

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.5.22

31.5.21

£

£

Taxation and social security

3,799

2,936

Other creditors

1,963

3,301

5,762

6,237